{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:15:04Z","timestamp":1787850904042,"version":"build-2784847793"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-genitourinary-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.clgc.2024.102087","type":"journal-article","created":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T17:47:39Z","timestamp":1712425659000},"page":"102087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Honing the Hunt: A Comprehensive Review of Cell-free Tumor DNA to Predict Neoadjuvant Therapy Efficacy in Bladder Cancer"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1364-5508","authenticated-orcid":false,"given":"Caio V.","family":"Suartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Motta","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maur\u00edcio D.","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz A.A.","family":"Botelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio P.","family":"Gallutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia R.M.","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Toren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Nahas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo A.","family":"Ribeiro-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clgc.2024.102087_bib0001","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.euo.2019.02.004","article-title":"Circulating tumor DNA alterations in advanced urothelial carcinoma and association with clinical outcomes: a pilot study","volume":"3","author":"Grivas","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2024.102087_bib0002","first-page":"209\u201149","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin. mai"},{"issue":"18","key":"10.1016\/j.clgc.2024.102087_bib0003","first-page":"1754\u201165","article-title":"Application of cell-free DNA analysis to cancer treatment","volume":"379","author":"Corcoran","year":"2018","journal-title":"N Engl J Med. nov"},{"key":"10.1016\/j.clgc.2024.102087_bib0004","doi-asserted-by":"crossref","first-page":"192\u2011237","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Planchard","year":"2018","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.clgc.2024.102087_bib0005","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","article-title":"Liquid biopsy: monitoring cancer-genetics in the blood","volume":"10","author":"Crowley","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2024.102087_bib0006","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: genotyping circulating tumor DNA","volume":"32","author":"Diaz","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clgc.2024.102087_bib0007","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: towards implementation of circulating tumor DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.clgc.2024.102087_bib0008","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.eururo.2016.12.016","article-title":"Liquid biopsy analysis of FGFR3 and PIK3CA hotspot mutations for disease surveillance in bladder cancer","volume":"71","author":"Christensen","year":"2017","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2024.102087_bib0009","first-page":"403","article-title":"The UBC-40 urothelial bladder cancer cell line index: a genomic resource for functional studies","volume":"16","author":"Earl","year":"2015","journal-title":"Bmc Genomics [Electronic Resource]"},{"issue":"6","key":"10.1016\/j.clgc.2024.102087_bib0010","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ng.3557","article-title":"Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors","volume":"48","author":"Kim","year":"2016","journal-title":"Nat Genet"},{"issue":"136","key":"10.1016\/j.clgc.2024.102087_bib0011","doi-asserted-by":"crossref","first-page":"136ra68","DOI":"10.1126\/scitranslmed.3003726","article-title":"Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA","volume":"4","author":"Forshew","year":"2012","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.clgc.2024.102087_bib0012","doi-asserted-by":"crossref","first-page":"532\u201144","DOI":"10.1111\/bju.14808","article-title":"Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification: 23-gene panel for urinary UBC diagnosis","volume":"124","author":"Ward","year":"2019","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.clgc.2024.102087_bib0013","doi-asserted-by":"crossref","first-page":"e22668","DOI":"10.1002\/jcla.22668","article-title":"New method to preserve the original proportion and integrity of urinary cell-free DNA","volume":"33","author":"Li","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.clgc.2024.102087_bib0014","doi-asserted-by":"crossref","first-page":"60\u20113","DOI":"10.1016\/j.clinbiochem.2018.11.009","article-title":"Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer","volume":"64","author":"Stasik","year":"2019","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clgc.2024.102087_bib0015","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.clgc.2024.102087_bib0016","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"issue":"7867","key":"10.1016\/j.clgc.2024.102087_bib0017","doi-asserted-by":"crossref","first-page":"432\u20117","DOI":"10.1038\/s41586-021-03642-9","article-title":"ctDNA guiding adjuvant immunotherapy in urothelial carcinoma","volume":"595","author":"Powles","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.clgc.2024.102087_bib0018","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1038\/s41598-017-05623-3","article-title":"Association of plasma and urinary mutant DNA with clinical outcomes in muscle invasive bladder cancer","volume":"7","author":"Patel","year":"2017","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.clgc.2024.102087_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003732","article-title":"Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: a cohort study","volume":"18","author":"Chauhan","year":"2021","journal-title":"PLOS Med"},{"issue":"18","key":"10.1016\/j.clgc.2024.102087_bib0020","doi-asserted-by":"crossref","first-page":"1547\u201157","DOI":"10.1200\/JCO.18.02052","article-title":"Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma","volume":"37","author":"Christensen","year":"2019","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.clgc.2024.102087_bib0021","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.euo.2023.03.008","article-title":"Cell-free DNA methylation as a predictive biomarker of response to neoadjuvant chemotherapy for patients with muscle-invasive bladder cancer in SWOG S1314","volume":"6","author":"Lu","year":"2023","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"10.1016\/j.clgc.2024.102087_bib0022","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"22","key":"10.1016\/j.clgc.2024.102087_bib0023","doi-asserted-by":"crossref","first-page":"8604\u201110","DOI":"10.1021\/ac202028g","article-title":"High-throughput droplet digital PCR system for absolute quantitation of DNA copy number","volume":"83","author":"Hindson","year":"2011","journal-title":"Anal Chem"},{"issue":"6","key":"10.1016\/j.clgc.2024.102087_bib0024","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3390\/ph14060596","article-title":"cfDNA sequencing: technological approaches and bioinformatic issues","volume":"14","author":"Bohers","year":"2021","journal-title":"Pharmaceuticals."},{"issue":"6","key":"10.1016\/j.clgc.2024.102087_bib0025","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/jamaoncol.2023.0425","article-title":"Early detection of molecular residual disease and risk stratification for stage I to III colorectal cancer via circulating tumor DNA methylation","volume":"9","author":"Mo","year":"2023","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.clgc.2024.102087_bib0026","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/s41591-023-02226-6","article-title":"A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer","volume":"29","author":"Assaf","year":"2023","journal-title":"Nat Med"},{"issue":"23","key":"10.1016\/j.clgc.2024.102087_bib0027","doi-asserted-by":"crossref","first-page":"9530\u20115","DOI":"10.1073\/pnas.1105422108","article-title":"Detection and quantification of rare mutations with massively parallel sequencing","volume":"108","author":"Kinde","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.clgc.2024.102087_bib0028","doi-asserted-by":"crossref","first-page":"269\u201177","DOI":"10.1093\/dnares\/dsv010","article-title":"High-fidelity target sequencing of individual molecules identified using barcode sequences: de novo detection and absolute quantitation of mutations in plasma cell-free DNA from cancer patients","volume":"22","author":"Kukita","year":"2015","journal-title":"DNA Res"},{"issue":"3","key":"10.1016\/j.clgc.2024.102087_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/ijms13033245","article-title":"Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases","volume":"13","author":"Stuppia","year":"2012","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.clgc.2024.102087_bib0030","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1158\/2159-8290.CD-18-0825","article-title":"Detection and surveillance of bladder cancer using urine tumor DNA","volume":"9","author":"Dudley","year":"2019","journal-title":"Cancer Discov"},{"issue":"7","key":"10.1016\/j.clgc.2024.102087_bib0031","doi-asserted-by":"crossref","first-page":"92736","DOI":"10.1373\/clinchem.2018.301341","article-title":"Noninvasive detection of bladder cancer by shallow-depth Genome-wide Bisulfite sequencing of urinary cell-free DNA for methylation and copy number profiling","volume":"65","author":"Cheng","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.clgc.2024.102087_bib0032","first-page":"4318","article-title":"Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer","volume":"44","author":"Avogbe","year":"2019","journal-title":"E Bio Medicine"},{"issue":"18","key":"10.1016\/j.clgc.2024.102087_bib0033","doi-asserted-by":"crossref","first-page":"13767","DOI":"10.3390\/ijms241813767","article-title":"CTC, ctDNA, and exosome in thyroid cancers: a review","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.clgc.2024.102087_bib0034","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3390\/cancers12061400","article-title":"Urinary biomarkers in bladder cancer: where do we stand and potential role of extracellular vesicles","volume":"12","author":"Oliveira","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.clgc.2024.102087_bib0035","series-title":"Poster pr\u00e9sent\u00e9 \u00e0: ASCO","article-title":"Correlation of circulating tumor DNA assessment with tissue-based comprehensive genomic profilling (CGP) in advanced urothelial cancer","author":"McGregor","year":"2018"},{"issue":"8","key":"10.1016\/j.clgc.2024.102087_bib0036","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli","year":"2004","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.clgc.2024.102087_bib0038","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1002\/ijc.29324","article-title":"Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity","volume":"136","author":"Madhavan","year":"2015","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.clgc.2024.102087_bib0039","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","article-title":"MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer","volume":"110","author":"Taylor","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.clgc.2024.102087_bib0040","first-page":"71","article-title":"Extracellular vesicles in urologic malignancies: an update","volume":"16","author":"Soria","year":"2019","journal-title":"Nat Rev Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324000582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324000582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T04:01:16Z","timestamp":1717646476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767324000582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1558767324000582"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102087","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Honing the Hunt: A Comprehensive Review of Cell-free Tumor DNA to Predict Neoadjuvant Therapy Efficacy in Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102087"}}